Cargando…
Integration Analysis of Pharmacokinetics and Metabolomics to Predict Metabolic Phenotype and Drug Exposure of Remdesivir
Remdesivir has displayed pharmacological activity against SARS-CoV-2. However, no pharmacometabolomics (PM) or correlation analysis with pharmacokinetics (PK) was revealed. Rats were intravenously administered remdesivir, and a series of blood samples were collected before and after treatment. Compr...
Autores principales: | Du, Ping, Wang, Guoyong, Hu, Ting, Li, Han, An, Zhuoling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8766850/ https://www.ncbi.nlm.nih.gov/pubmed/35069201 http://dx.doi.org/10.3389/fphar.2021.779135 |
Ejemplares similares
-
Integrative Analysis of Pharmacokinetic and Metabolomic Profiles for Predicting Metabolic Phenotype and Drug Exposure Caused by Sotorasib in Rats
por: Du, Ping, et al.
Publicado: (2022) -
Dose- and time-dependent manners of moxifloxacin induced liver injury by targeted metabolomics study
por: Hu, Ting, et al.
Publicado: (2022) -
Eicosanoid Metabolomic Profile of Remdesivir Treatment in Rat Plasma by High-Performance Liquid Chromatography Mass Spectrometry
por: Du, Ping, et al.
Publicado: (2021) -
Population Pharmacokinetics of Remdesivir and GS-441524 in Hospitalized COVID-19 Patients
por: Leegwater, E., et al.
Publicado: (2022) -
Integrating metabolomics, bionics, and culturomics to study probiotics-driven drug metabolism
por: Li, Bohai, et al.
Publicado: (2023)